文献詳細
文献概要
特集 一般・消化器外科医のための できる! 漢方 がん化学療法完遂のための漢方
食欲不振,嘔気,嘔吐
著者: 大西俊介1
所属機関: 1北海道大学大学院医学研究院内科学分野消化器内科学教室
ページ範囲:P.328 - P.333
文献購入ページに移動【ポイント】
◆がん化学療法に伴う嘔気・嘔吐・食欲不振に対する現在の標準的な支持療法はいまだ十分とはいえない.
◆六君子湯(りっくんしとう)はセロトニン受容体に対する拮抗作用およびグレリンを介した食欲増進作用が明らかとなっている.
◆六君子湯は標準制吐療法に対する上乗せ効果が期待されているが,プラセボを用いた質の高い臨床試験の結果が待たれる.
◆がん化学療法に伴う嘔気・嘔吐・食欲不振に対する現在の標準的な支持療法はいまだ十分とはいえない.
◆六君子湯(りっくんしとう)はセロトニン受容体に対する拮抗作用およびグレリンを介した食欲増進作用が明らかとなっている.
◆六君子湯は標準制吐療法に対する上乗せ効果が期待されているが,プラセボを用いた質の高い臨床試験の結果が待たれる.
参考文献
1)Hesketh PJ:Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482-2494, 2008
2)Cubeddu LX, Hoffmann IS:Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy:effects of antiemetics. J Clin Pharmacol 33:691-697, 1993
3)Saito R, Takano Y, Kamiya HO:Roles of substance P and NK(1) receptor in the brainstem in the development of emesis. J Pharmacol Sci 91:87-94, 2003
4)De Vry J, Schreiber R:Effects of selected serotonin 5-HT(1) and 5-HT(2) receptor agonists on feeding behavior:possible mechanisms of action. Neurosci Biobehav Rev 24:341-353, 2000
5)Hayashi A, Suzuki M, Sasamata M, et al:Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats. Psychopharmacology(Berl)178:241-249, 2005
6)Roila F, Herrstedt J, Aapro M, et al:Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting:results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232-243, 2010
7)Ioannidis JP, Hesketh PJ, Lau J:Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting:a meta-analysis of randomized evidence. J Clin Oncol 18:3409-3422, 2000
8)Jordan K, Jahn F, Aapro M:Recent developments in the prevention of chemotherapy-induced nausea and vomiting(CINV):a comprehensive review. Ann Oncol 26:1081-1090, 2015
9)Herrstedt J, Roila F, Warr D, et al:2016 Updated MASCC/ESMO consensus recommendations:prevention of nausea and vomiting following high emetic risk chemotherapy. Support Care Cancer 25:277-288, 2016
10)Saito M, Aogi K, Sekine I, et al:Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy:a double-blind, double-dummy, randomised, comparative phase Ⅲ trial. Lancet Oncol 10:115-124, 2009
11)Schmoll HJ, Aapro MS, Poli-Bigelli S, et al:Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment. Ann Oncol 17:1000-1006, 2006
12)Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, et al:Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer 97:3090-3098, 2003
13)Hesketh PJ, Grunberg SM, Gralla RJ, et al:The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting:a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group. J Clin Oncol 21:4112-4119, 2003
14)Hesketh PJ, Bohlke K, Lyman GH, et al:Antiemetics:American Society of Clinical Oncology focused guideline update. J Clin Oncol 34:381-386, 2016
15)Chow R, Chiu L, Navari R, et al:Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting(CINV)as reported in phase Ⅰ and Ⅱ studies:a systematic review. Support Care Cancer 24:1001-1008, 2016
16)Kido T, Nakai Y, Kase Y, et al:Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine. J Pharmacol Sci 98:161-167, 2005
17)Hayakawa T, Arakawa T, Kase Y, et al:Liu-Jun-Zi-Tang, a kampo medicine, promotes adaptive relaxation in isolated guinea pig stomachs. Drugs Exp Clin Res 25:211-218, 1999
18)Kojima M, Hosoda H, Date Y, et al:Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999
19)Hattori T:Rikkunshito and ghrelin. Int J Pept 2010:pii:283549, 2010
20)Takeda H, Sadakane C, Hattori T, et al:Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism. Gastroenterology 134:2004-2013, 2008
21)Tominaga K, Kido T, Ochi M, et al:The traditional Japanese medicine rikkunshito promotes gastric emptying via the antagonistic action of the 5-HT3 receptor pathway in rats. Evid Based Complement Alternat Med 2011:248481, 2011
22)三好秋馬,谷内 昭,正宗 研:慢性胃炎などの不定の消化器愁訴に対するTJ-43ツムラ六君子湯の臨床評価Cisapride(CPD)を対照薬とした多施設比較試験.Prog Med 11:1605-1631, 1991
23)Tatsuta M, Iishi H:Effect of treatment with liu-jun-zi-tang(TJ-43)on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 7:459-462, 1993
24)原澤 茂,三好秋馬,三輪 剛,他:運動不全型の上腹部愁訴(dysmotility-like dyspepsia)に対するTJ-43六君子湯の多施設共同市販後臨床試験 二重盲検群間比較法による検討.医学のあゆみ187:207-229,1998
25)合地 明,広瀬周平,佐藤克明:胃切除術後の消化器症状に対する半夏瀉心湯,六君子湯の効果.日消外会誌28:961-965,1995
26)中島 修,袁世 華:機能性ディスペプシアに対する漢方製剤,六君子湯の臨床効果の比較検討.医学と薬学59:235-240,2008
27)遠藤 剛:機能性ディスペプシアに対する六君子湯の有効性の検討.医学と薬学60:547-552,2008
28)Oka T, Tamagawa Y, Hayashida S, et al:Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine. Biopsychosoc Med 1:21, 2007
29)Tomono H, Ito Y, Watanabe T:[Successful antiemetic treatment of TSUMURA Rikkunshi-to Extract Granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient]. Gan To Kagaku Ryoho 33:1129-1131, 2006
30)Seike J, Sawada T, Kawakita N, et al:A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP. Int J Surg Oncol 2011:715623, 2011
31)日高隆雄:【産科婦人科疾患と漢方Up to Date 2011】産科婦人科領域でまず使ってみたい漢方薬 癌化学療法の副作用対策 筋肉痛,悪心・嘔吐[芍薬甘草湯,六君子湯].漢方医学35:47-51,2011
32)鈴木弘行,武藤哲史,岡部直行,他:がん化学療法の副作用対策としての漢方治療 肺癌化学療法における制吐療法としてのアプレピタント,六君子湯併用療法の有用性.日癌治療会誌45:382,2010
33)Ohno T, Yanai M, Ando H, et al:Rikkunshito, a traditional Japanese medicine, suppresses cisplatin-induced anorexia in humans. Clin Exp Gastroenterol 4:291-296, 2011.
34)Ohnishi S, Watari H, Kanno M, et al:Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel:results of a randomized phase Ⅱ study(JORTC KMP-02). J Gynecol Oncol 28:e44, 2017
35)Harada T, Amano T, Ikari T, et al:Rikkunshito for preventing chemotherapy-induced nausea and vomiting in lung cancer patients:results from 2 prospective, randomized phase 2 trials. Front Pharmacol 8:972, 2017
36)Tominaga K, Kato M, Takeda H, et al:A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor:the G-PRIDE study. J Gastroenterol 49:1392-1405, 2014
掲載誌情報